Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

<p>In-vitro blood-brain barrier models for drug screening and permeation studies: an overview</p>
Sounak Bagchi, Tanya Chhibber, Behnaz Lahooti, et al.
Drug Design Development and Therapy (2019) Vol. Volume 13, pp. 3591-3605
Open Access | Times Cited: 189

Showing 1-25 of 189 citing articles:

The blood-brain barrier in aging and neurodegeneration
Emily G. Knox, María R. Aburto, Gerard Clarke, et al.
Molecular Psychiatry (2022) Vol. 27, Iss. 6, pp. 2659-2673
Open Access | Times Cited: 371
The Bioavailability of Drugs—The Current State of Knowledge
Marlena Stielow, Adrianna Witczyńska, Natalia Kubryń, et al.
Molecules (2023) Vol. 28, Iss. 24, pp. 8038-8038
Open Access | Times Cited: 105
An optimized ionizable cationic lipid for brain tumor-targeted siRNA delivery and glioblastoma immunotherapy
Shuhan Liu, Ji Liu, Haisong Li, et al.
Biomaterials (2022) Vol. 287, pp. 121645-121645
Closed Access | Times Cited: 78
Multifunctional Nanotheranostics for Overcoming the Blood–Brain Barrier
M H Miran Beygi, Fatemeh Oroojalian, Soheil Azizi‐Arani, et al.
Advanced Functional Materials (2024) Vol. 34, Iss. 19
Closed Access | Times Cited: 24
Precision drug delivery to the central nervous system using engineered nanoparticles
Jingjing Gao, Ziting Xia, Swetharajan Gunasekar, et al.
Nature Reviews Materials (2024) Vol. 9, Iss. 8, pp. 567-588
Closed Access | Times Cited: 24
In vitro modeling of the neurovascular unit: advances in the field
Aditya Bhalerao, Farzane Sivandzade, Sabrina Rahman Archie, et al.
Fluids and Barriers of the CNS (2020) Vol. 17, Iss. 1
Open Access | Times Cited: 122
Recent Advances in the Prediction of Pharmacokinetics Properties in Drug Design Studies: A Review
Simone Queiroz Pantaleão, Philipe Oliveira Fernandes, José Eduardo Gonçalves, et al.
ChemMedChem (2021) Vol. 17, Iss. 1
Closed Access | Times Cited: 102
Development of a Roadmap for Action on New Approach Methodologies in Risk Assessment
Sylvia E. Escher, Falko Partosch, Sebastian Konzok, et al.
EFSA Supporting Publications (2022) Vol. 19, Iss. 6
Open Access | Times Cited: 64
Brain Disposition of Antibody-Based Therapeutics: Dogma, Approaches and Perspectives
Aida Kouhi, Vyshnavi Pachipulusu, Talya Kapenstein, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 12, pp. 6442-6442
Open Access | Times Cited: 63
An updated review on the versatile role of chrysin in neurological diseases: Chemistry, pharmacology, and drug delivery approaches
Marjan Talebi, Mohsen Talebi, Tahereh Farkhondeh, et al.
Biomedicine & Pharmacotherapy (2021) Vol. 141, pp. 111906-111906
Open Access | Times Cited: 60
The Relationship Between the Blood-Brain-Barrier and the Central Effects of Glucagon-Like Peptide-1 Receptor Agonists and Sodium-Glucose Cotransporter-2 Inhibitors
Meiyuan Dong, Song Wen, Ligang Zhou
Diabetes Metabolic Syndrome and Obesity (2022) Vol. Volume 15, pp. 2583-2597
Open Access | Times Cited: 44
Surface-fill H2S-releasing silk fibroin hydrogel for brain repair through the repression of neuronal pyroptosis
Xueshi Chen, Xinqi Huang, Chao Liu, et al.
Acta Biomaterialia (2022) Vol. 154, pp. 259-274
Open Access | Times Cited: 40
Sickness behaviour and depression: An updated model of peripheral-central immunity interactions
Federico Turkheimer, Mattia Veronese, Valeria Mondelli, et al.
Brain Behavior and Immunity (2023) Vol. 111, pp. 202-210
Open Access | Times Cited: 34
Advances in nanotechnology versus stem cell therapy for the theranostics of Huntington's disease
Ghulam Mustafa Channa, Dilawar Hassan, Mahira Zeeshan, et al.
Journal of Drug Delivery Science and Technology (2023) Vol. 87, pp. 104774-104774
Open Access | Times Cited: 34
From cells to organoids: The evolution of blood-brain barrier technology for modelling drug delivery in brain cancer
Estrella Gonzales‐Aloy, Aria Ahmed-Cox, Maria Tsoli, et al.
Advanced Drug Delivery Reviews (2023) Vol. 196, pp. 114777-114777
Closed Access | Times Cited: 27
Advances in TEER measurements of biological barriers in microphysiological systems
Hojjatollah Nazari, Jesus Shrestha, Vahid Yaghoubi Naei, et al.
Biosensors and Bioelectronics (2023) Vol. 234, pp. 115355-115355
Closed Access | Times Cited: 23
Identification of Novel Quinolone and Quinazoline Alkaloids as Phosphodiesterase 10A Inhibitors for Parkinson’s Disease through a Computational Approach
Iqra Ahmad, Hira Khalid, Asia Perveen, et al.
ACS Omega (2024) Vol. 9, Iss. 14, pp. 16262-16278
Open Access | Times Cited: 11
Device-assisted strategies for drug delivery across the blood-brain barrier to treat glioblastoma
Nassir Mokarram, Ayden Case, Nadia N. Hossainy, et al.
Communications Materials (2025) Vol. 6, Iss. 1
Open Access | Times Cited: 1
Recent advances in 3D bioprinted neural models: A systematic review on the applications to drug discovery
Amanda Orr, Farnoosh Kalantarnia, Shama Nazir, et al.
Advanced Drug Delivery Reviews (2025) Vol. 218, pp. 115524-115524
Open Access | Times Cited: 1
Ginsenoside Rb1 alleviates blood-brain barrier damage and demyelination in experimental autoimmune encephalomyelitis mice by regulating JNK/ ERK/NF-κB signaling pathway
Yingying Song, Xiaojuan Zhang, Xinyan Han, et al.
Journal of Ethnopharmacology (2025), pp. 119448-119448
Closed Access | Times Cited: 1
Masked Graph Transformer for Blood-Brain Barrier Permeability Prediction
Tuan Vinh, Phuc H. Le, Binh P. Nguyen, et al.
Journal of Molecular Biology (2025), pp. 168983-168983
Closed Access | Times Cited: 1
Hepatic and Extra-Hepatic Metabolism of Propylene Glycol Ethers in the Context of Central Nervous System Toxicity
Sophie Werner, David Pamies, Marie‐Gabrielle Zurich, et al.
Toxicology (2025) Vol. 512, pp. 154081-154081
Closed Access | Times Cited: 1
Perspectives of characterization and bioconjugation of gold nanoparticles and their application in lateral flow immunosensing
Vivek Borse, Aditya Narayan Konwar, Rahul Dev Jayant, et al.
Drug Delivery and Translational Research (2020) Vol. 10, Iss. 4, pp. 878-902
Closed Access | Times Cited: 65
Increased serum peripheral C-reactive protein is associated with reduced brain barriers permeability of TSPO radioligands in healthy volunteers and depressed patients: implications for inflammation and depression
Federico Turkheimer, Noha Althubaity, Julia Schubert, et al.
Brain Behavior and Immunity (2020) Vol. 91, pp. 487-497
Open Access | Times Cited: 63
In situ sensors for blood-brain barrier (BBB) on a chip
Yan Liang, Jeong‐Yeol Yoon
Sensors and Actuators Reports (2021) Vol. 3, pp. 100031-100031
Open Access | Times Cited: 55
Page 1 - Next Page

Scroll to top